Cargando…

T(2)-FLAIR Mismatch Sign Is Caused by Long T(1) and T(2) of IDH-mutant, 1p19q Non-codeleted Astrocytoma

T(2)-fluid-attenuated inversion recovery images (FLAIR) mismatch sign is now known to be a specific yet insensitive image feature for IDH-mutant, 1p19q non-codeleted astrocytoma. The current study revealed that lesion presenting T(2)-FLAIR mismatch exhibited extremely long T(1)- and T(2)-relaxation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kinoshita, Manabu, Uchikoshi, Masato, Sakai, Mio, Kanemura, Yonehiro, Kishima, Haruhiko, Nakanishi, Katsuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese Society for Magnetic Resonance in Medicine 2020
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952199/ https://www.ncbi.nlm.nih.gov/pubmed/32101817 http://dx.doi.org/10.2463/mrms.bc.2019-0196

Ejemplares similares

Impact of Inversion Time for FLAIR Acquisition on the T2-FLAIR Mismatch Detectability for IDH-Mutant, Non-CODEL Astrocytomas
por: Kinoshita, Manabu, et al.
Publicado: (2021)

NI-12 The ratio of T1-Weighted to T2-Weighted Signal Intensity and IDH mutation in glioma
por: Sanada, Takahiro, et al.
Publicado: (2021)

NI-13 THE RATIO OF T1-WEIGHTED TO T2-WEIGHTED SIGNAL INTENSITY AND IDH MUTATION IN GLIOMA
por: Sanada, Takahiro, et al.
Publicado: (2022)

Correlation of T1- to T2-weighted signal intensity ratio with T1- and T2-relaxation time and IDH mutation status in glioma
por: Sanada, Takahiro, et al.
Publicado: (2022)

T2/FLAIR-mismatch sign for noninvasive detection of IDH-mutant 1p/19q non-codeleted gliomas: validity and pathophysiology
por: Foltyn, Martha, et al.
Publicado: (2020)

Prediction and Visualization of Non-Enhancing Tumor in Glioblastoma via T1w/T2w-Ratio Map
por: Yamamoto, Shota, et al.
Publicado: (2022)

NI-14 estimation of property of MRI non-contrast enhanced lesion of Glioblastoma using T1/T2 ratio
por: Yamamoto, Shota, et al.
Publicado: (2021)

NI-3 Magnetic resonance relaxometry for tumor cell density imaging for glioma: An exploratory study via 11C-methionine PET and its validation via stereotactic tissue sampling
por: Kinoshita, Manabu, et al.
Publicado: (2021)

Magnetic Resonance Relaxometry for Tumor Cell Density Imaging for Glioma: An Exploratory Study via (11)C-Methionine PET and Its Validation via Stereotactic Tissue Sampling
por: Kinoshita, Manabu, et al.
Publicado: (2021)

The T2-FLAIR Mismatch Sign as an Imaging Indicator of IDH-Mutant, 1p/19q Non-Codeleted Lower Grade Gliomas: A Systematic Review and Diagnostic Accuracy Meta-Analysis
por: Adamou, Antonis, et al.
Publicado: (2021)

Validation of magnetic resonance imaging-based automatic high-grade glioma segmentation accuracy via (11)C-methionine positron emission tomography
por: Ozaki, Tomohiko, et al.
Publicado: (2019)

NI-07 VALIDATION OF MACHINE LEARNING BASED HIGH GRADE GLIOMA MR SEGMENTATION VIA METHIONINE PET
por: Kinoshita, Manabu, et al.
Publicado: (2019)

SS-2 Current status and future perspective of radiomics in glioma imaging
por: Kinoshita, Manabu, et al.
Publicado: (2020)

Reverse Engineering Glioma Radiomics to Conventional Neuroimaging
por: KINOSHITA, Manabu, et al.
Publicado: (2021)

Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort
por: van Garderen, Karin A, et al.
Publicado: (2023)

Primary Leptomeningeal Oligodendroglioma, IDH-Mutant, 1p/19q-Codeleted
por: Ballester, Leomar Y., et al.
Publicado: (2018)

NI-2 Use of neurite orientation dispersion and density imaging(NODDI)for early distinction between infiltrating tumor and vasogenic edema in non-enhancing lesions with glioblastoma patients
por: Okita, Yoshiko, et al.
Publicado: (2021)

Cerebellar preference of luminal A and B type and basal ganglial preference of HER2-positive type breast cancer-derived brain metastases
por: Izutsu, Nobuyuki, et al.
Publicado: (2021)

Mismatch repair protein mutations in isocitrate dehydrogenase (IDH)-mutant astrocytoma and IDH-wild-type glioblastoma
por: Richardson, Timothy E, et al.
Publicado: (2023)

The Role of the T2–FLAIR Mismatch Sign as an Imaging Marker of IDH Status in a Mixed Population of Low- and High-Grade Gliomas
por: Kapsalaki, Eftychia Z., et al.
Publicado: (2020)

Enlargement of papillary glioneuronal tumor in an adult after a follow-up period of 10 years: a case report
por: Fujita, Yuya, et al.
Publicado: (2018)

Prognostic stratification for IDH-wild-type lower-grade astrocytoma by Sanger sequencing and copy-number alteration analysis with MLPA
por: Makino, Yasuhide, et al.
Publicado: (2021)

The T2‐FLAIR mismatch sign as an imaging biomarker for oligodendrogliomas in dogs
por: Garcia‐Mora, Josefa, et al.
Publicado: (2023)

IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas
por: Leeper, Heather E., et al.
Publicado: (2015)

Case report: Spinal drop metastasis of IDH-mutant, 1p/19q-codeleted oligodendroglioma
por: Karaman, Ahmet Kursat, et al.
Publicado: (2022)

Introduction of High Throughput Magnetic Resonance T2-Weighted Image Texture Analysis for WHO Grade 2 and 3 Gliomas
por: Kinoshita, Manabu, et al.
Publicado: (2016)

Multi-Parametric Radiomic Model to Predict 1p/19q Co-Deletion in Patients with IDH-1 Mutant Glioma: Added Value to the T2-FLAIR Mismatch Sign
por: Kihira, Shingo, et al.
Publicado: (2023)

Salvage therapies for radiation-relapsed isocitrate dehydrogenase-mutant astrocytoma and 1p/19q codeleted oligodendroglioma
por: Ma, Sirui, et al.
Publicado: (2021)

Predictive accuracy of T2-FLAIR mismatch sign for the IDH-mutant, 1p/19q noncodeleted low-grade glioma: An updated systematic review and meta-analysis
por: Do, Yoon Ah, et al.
Publicado: (2022)

Clinicopathological analysis of T2-FLAIR mismatch sign in lower-grade gliomas
por: Deguchi, Shoichi, et al.
Publicado: (2020)

Quantitative relaxometry using synthetic MRI could be better than T2-FLAIR mismatch sign for differentiation of IDH-mutant gliomas: a pilot study
por: Kikuchi, Kazufumi, et al.
Publicado: (2022)

Mass spectrometry-based assay for the molecular diagnosis of glioma: concomitant detection of chromosome 1p/19q codeletion, and IDH1, IDH2, and TERT mutation status
por: Pesenti, Chiara, et al.
Publicado: (2017)

Bone metastases from a 1p/19q codeleted and IDH1-mutant anaplastic oligodendroglioma: a case report
por: Burgy, Mickaël, et al.
Publicado: (2019)

Rare Cases of IDH1 Mutations in Spinal Cord Astrocytomas
por: Konovalov, N. A., et al.
Publicado: (2020)

Distribution differences in prognostic copy number alteration profiles in IDH-wild-type glioblastoma cause survival discrepancies across cohorts
por: Umehara, Toru, et al.
Publicado: (2019)

Radiomics-Based Method for Predicting the Glioma Subtype as Defined by Tumor Grade, IDH Mutation, and 1p/19q Codeletion
por: Li, Yingping, et al.
Publicado: (2022)

Case report: Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, associated with a germline mutation in PMS2
por: Merchant, Mythili, et al.
Publicado: (2022)

DWI-FLAIR Mismatch at MRI Versus Infarct-Penumbra Mismatch on CT Perfusion
por: Collard, Margaux, et al.
Publicado: (2019)

Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis
por: Suwala, Abigail K., et al.
Publicado: (2020)

NI-09 CLINICAL SIGNIFICANCE OF T2-FLAIR MISMATCH SIGN IN LOWER GRADE GLIOMAS
por: Deguchi, Shoichi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2p42slib6r3jdqv7uqshnqsc8n